Department of Nephrology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus, Denmark.
Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus, Denmark.
J Cardiovasc Comput Tomogr. 2017 Sep-Oct;11(5):389-396. doi: 10.1016/j.jcct.2017.07.001. Epub 2017 Jul 4.
Patients with chronic kidney disease (CKD) have an increased risk of cardiovascular events. Previous studies using 2-dimensional echocardiography show that left atrial end-diastolic volume (LAEDV) predicts cardiovascular outcomes and mortality in patients with CKD. However, contrast-enhanced cardiac CT may offers a more precise measure of atrial dimensions and function than 2-dimensional echocardiography and may provide improved predictionof patient outcome.
The aim of the present study was to examine the association of LAEDV and left atrial ejection fraction (LAEF) assessed by CT with left ventricle end-diastolic volume (LVEDV), left ventricular mass, left ventricular ejection fraction and N-terminal plasma-pro-brain natriuretic peptide (NT-PRO-BNP). Furthermore, we examined LAEDV and LAEF as predictors of major adverse cardiac events (MACE) and mortality.
Kidney transplant candidates (n = 117) underwent contrast-enhanced CT screening for coronary artery disease as part of the work-up prior to kidney transplantation before being accepted on the transplantation waiting list. Left atrial (LA) and left ventricular (LV) volume and function were determined by cardiac CT. MACE and mortality data were extracted from the Western Denmark Heart Registry, a review of patient records and patient interviews.
Baseline patient characteristics did not differ between LAEDV tertiles. LAEDV was positively associated with measures of LV function - both LVEDV (β = 0.36, p < 0.05) and LV mass (β = 0.30, p < 0.05). LAEF was not associated with measures of LV function. LAEDV was positively and LAEF negatively associated with NT-PRO-BNP (LAEDV: β = 10.28, p < 0.05. LAEF: β = -0.06, p < 0.05). During a median follow-up of 3.7-years, 19 (16.2%) patients died and 19 (16.2%) patients suffered MACE. MACE and survival analysis showed no relation to LAEDV or LAEF.
Using contrast-enhanced CT, we demonstrated a correlation between atrial and ventricular functional parameters. However, we found no association with either LAEF or LAEDV or MACE and mortality in this cohort of kidney transplant candidates.
慢性肾脏病(CKD)患者发生心血管事件的风险增加。既往使用二维超声心动图的研究表明,左心房舒张末期容积(LAEDV)可预测 CKD 患者的心血管结局和死亡率。然而,对比增强心脏 CT 可能比二维超声心动图更精确地测量心房的大小和功能,并可能改善患者预后的预测。
本研究旨在探讨 CT 评估的左心房舒张末期容积(LAEDV)和左心房射血分数(LAEF)与左心室舒张末期容积(LVEDV)、左心室质量、左心室射血分数和 N 末端血浆脑钠肽前体(NT-PRO-BNP)之间的关系。此外,我们还探讨了 LAEDV 和 LAEF 作为主要不良心脏事件(MACE)和死亡率的预测因子。
作为肾移植前接受肾移植的工作流程的一部分,117 例肾移植候选者接受了对比增强 CT 筛查以排除冠状动脉疾病。通过心脏 CT 确定左心房(LA)和左心室(LV)的容积和功能。MACE 和死亡率数据从西部丹麦心脏登记处提取,该登记处是对患者记录和患者访谈的审查。
基线患者特征在 LAEDV 三分位数之间没有差异。LAEDV 与 LV 功能的各项指标均呈正相关,包括 LVEDV(β=0.36,p<0.05)和 LV 质量(β=0.30,p<0.05)。LAEF 与 LV 功能的各项指标无关。LAEDV 与 NT-PRO-BNP 呈正相关,而 LAEF 呈负相关(LAEDV:β=10.28,p<0.05;LAEF:β=-0.06,p<0.05)。在中位随访 3.7 年期间,19 例(16.2%)患者死亡,19 例(16.2%)患者发生 MACE。MACE 和生存分析显示 LAEDV 或 LAEF 与两者均无关。
使用对比增强 CT,我们在该队列的肾移植候选者中证明了心房和心室功能参数之间存在相关性。然而,我们没有发现 LAEF 或 LAEDV 与 MACE 和死亡率之间存在任何关联。